[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100547068":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":10,"locations":20,"responsibleParty":43,"collaborators":10,"id":45,"slug":46,"hasResults":47,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":51,"eligibilityCriteria":52,"healthyVolunteers":47,"sex":53,"minAge":10,"maxAge":10,"enrollmentInfo":54,"targetDuration":57,"studyType":58,"phases":10,"briefSummary":59,"conditions":60,"keywords":69,"overallStatus":23,"whyStopped":10,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"Erasme University Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Transfused patients",null,"patients who received an hemostatic product",[13],"Procedure: Transfusion",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"PROCEDURE","Transfusion","Transfusion of an hemostatic product",[9],[21],{"facility":22,"status":23,"city":24,"state":10,"zip":25,"country":26,"countryCode":27,"cosmosGeoPoint":28,"geoPoint":33,"contacts":34},"Université libre de Bruxelles","RECRUITING","Anderlecht","1070","Belgium","BE",{"type":29,"coordinates":30},"Point",[31,32],4.31454,50.83619,{"lat":32,"lon":31},[35,40],{"name":36,"role":37,"phone":38,"phoneExt":10,"email":39},"Oliver Duranteau, M.D.","CONTACT","+3225553919","olivier.duranteau@erasme.ulb.ac.be",{"name":41,"role":42,"phone":10,"phoneExt":10,"email":10},"Olivier DURANTEAU, M.D.","PRINCIPAL_INVESTIGATOR",{"type":44,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100547068","transfusion-surveillance-in-anaesthesia-100547068",false,"NCT06403163","Transfusion Surveillance in Anaesthesia","Biological Transfusion Efficiency Registry Transfusion Surveillance in Anaesthesia","STAR","Inclusion Criteria:\n\n* all patients who have received an hemostasis product\n\nExclusion Criteria:\n\n* patient who refused to consent to data analysis and study participation","ALL",{"count":55,"type":56},50000,"ESTIMATED","2 Weeks","OBSERVATIONAL","the aim of this register is to collect exhaustively the different data available surrounding a transfusion act in the context of an active haemorrhage. The aim is to allow different modelling and analysis related to emergency transfusion.",[61,62,63,64,65,66,67,68],"Transfusion Reaction","Transfusion Related Complication","Anesthesia","Anesthesia; Shock","Side Effect","Fresh Blood Stool","Blood Coagulation Disorder","Blood Loss",[70,71,72,73,74],"transfusion","monitoring","emergency situation","shock","fresh frozen plasma","2025-08-25",{"date":77,"type":78},"2025-09-02","ACTUAL",{"date":80,"type":78},"2022-09-01",{"date":82,"type":56},"2030-12-31",{"name":5,"class":6},1]